Source:http://linkedlifedata.com/resource/pubmed/id/10354719
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1999-7-16
|
pubmed:abstractText |
The congestive heart failure is an important clinical problem because of its frequency of appearance and poor prognosis. A new groups of drugs are to be found to change the negative natural course of this disease. Beta adrenolytic agents are on focus now because of promising results of small and great clinical trials and wider knowledge about the pathophysiology of congestive heart failure. This paper presents the present day knowledge about the role of the beta blockers therapy in the congestive heart failure treatment.
|
pubmed:language |
pol
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0033-2240
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
669-72
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading | |
pubmed:year |
1998
|
pubmed:articleTitle |
[Present day opinion about beta block treatment of congestive heart failure].
|
pubmed:affiliation |
Kliniki Choroby Wie?cowej, Instytutu Kardiologii Collegium Medicum, Uniwersytetu Jagiello?skiego w Krakowie.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|